A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Clinical trial NCT04861090 · COMPLETED

Trial details

NCT number: NCT04861090
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema (HAE)

Start date: 2021-09-15
Primary completion: 2022-06-30
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.